Recent advances on T-cell regulation by receptor tyrosine kinases

Current Opinion in Hematology

Volumn 12, Issue 4, 2005, Pages 292-297

  Wu, Jiangping ^b   Luo, Hongyu ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

Ephrins; Erythropoietin producing hepatocyte kinases; Lymphoid organ structure; Receptor tyrosine kinase; T cell costimulation

Indexed keywords

EPHRIN; ERYTHROPOIETIN PRODUCING HEPATOCYTE KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; CELL ADHESION; CELL MATURATION; CROSS LINKING; HUMAN; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; EPHRINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, EPH FAMILY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 23044489567     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moh.0000166497.26397.9f     Document Type: Review

References (34)

1. Dikov MM, Ohm JE, Ray N, et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J Immunol 2005; 174:215-222. This article describes the role of platelet-derived growth factor receptor members Flk-1, and Flt-1 in dendritic cell maturation.
2. Westermann J, Nguyen-Hoai T, Mollweide A, et al. Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization. Gene Ther 2004; 11:1048-1056. This article reports that using Flt-3L (the ligand of a platelet-derived growth factor receptor member Flt-3) as adjuvant for immunization leads to enhanced Th2-type immune responses.
3. Eph Nomenclature Committee. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 1997; 90:403-404.
4. Wilkinson DG. Eph receptors and ephrins: regulators of guidance and assembly. Int Rev Cytol 2000; 196:177-244.
5. Flanagan JG, Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci 1998; 21:309-345.
6. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998; 93:741-753.
7. Batlle E, Henderson JT, Beghtel H, et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002; 111:251-263.
8. Dravis C, Yokoyama N, Chumley MJ, et al. Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. Dev Biol 2004; 271:272-290.
9. Gurniak CB, Berg LJ. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. Oncogene 1996; 13:777-786.
10. Luo H, Yu G, Wu Y, Wu J. EphB6 crosslinking results in costimulation of T cells. J Clin Invest 2002; 110:1141-1150.
11. -/- mice, the magnitude of delayed-type hypersensitivity and experimental autoimmune encephalitis is reduced.
12. Yu G, Luo H, Wu Y, Wu J. Mouse ephrinB3 augments T-cell signaling and responses to T-cell receptor ligation. J Biol Chem 2003; 278:47209-47216.
13. Yu G, Luo H, Wu Y, Wu J. EphrinB2 induces T cell costimulation. J Immunol 2003; 171:106-114.
14. Yu G, Luo H, Wu Y, Wu J. EphrinB1 is essential in T-cell-T-cell co-operation during T-cell activation. J Biol Chem 2004; 279:55531-55539. Ephrin B1 costimulates T cells in terms of cytokine secretion and proliferation, although it fails to stimulate interleukin-2 production. With EFNB1 costimulation, unlike anti-CD28 costimulation, Akt activation is not achieved.
15. Pascall JC, Brown KD. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. Biochem Biophys Res Commun 2004; 317:244-252. This article reveals a novel mechanism of intramembrane EFN B3 cleavage by a rhomboid protease.
16. Shimoyama M, Matsuoka H, Nagata A, et al. Developmental expression of EphB6 in the thymus: lessons from EphB6 knockout mice. Biochem Biophys Res Commun 2002; 298:87-94.
17. Wohlfahrt JG, Karagiannidis C, Kunzmann S, et al. Ephrin-A1 suppresses Th2 cell activation and provides a regulatory link to lung epithelial cells. J Immunol 2004; 172:843-850. The authors show that cross-linking EFNA1 preferentially leads to reduced Th2-type T-cell responses, indicating that reverse signaling through EFNA1 modulates T-cell function.
18. Luo H, Wan X, Wu Y, Wu J. Cross-linking of EphB6 resulting in signal transduction and apoptosis in Jurkat cells. J Immunol 2001; 167:1362-1370.
19. Freywald A, Sharfe N, Rashotte C, et al. The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses. J Biol Chem 2003; 278:10150-10156.
20. Munoz JJ, Alonso CLM, Sacedon R, et al. Expression and function of the Eph A receptors and their ligands ephrins A in the rat thymus. J Immunol 2002; 169:177-184.
21. Coles MC, Adams R, Adams S, et al. The role of Eph receptors and Ephrins in T cell development in the thymus. Clin Invest Med 2004; 27:56D. The authors provide the first evidence that disturbing Eph expression leads to abnormal lymphoid organ structure.
22. Sharfe N, Freywald A, Toro A, et al. Ephrin stimulation modulates T cell chemotaxis. Eur J Immunol 2002; 32:3745-3755.
23. Aasheim HC, Delabie J, Finne EF. Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2. Blood 2005; 105:2869-2876. CD4 cells bound by aggregated EFNA1 have enhanced chemotaxis towards stromal cell-derived factor 1 and macrophage inflammatory protein 3β.
24. Smith LM, Walsh PT, Rudiger T, et al. EphA3 is induced by CD28 and IGF-1 and regulates cell adhesion. Exp Cell Res 2004; 292:295-303.
25. Freywald A, Sharfe N, Roifman CM. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. J Biol Chem 2002; 277:3823-3828.
26. Wang Y, Ota S, Kataoka H, et al. Negative regulation of EphA2 receptor by Cb1. Biochem Biophys Res Commun 2002; 296:214-220.
27. Sharfe N, Freywald A, Toro A, Roifman CM. Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells. J Immunol 2003; 170:6024-6032.
28. Thien CB, Langdon WY. Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2001; 2:294-307.
29. Zhang W, Sloan-Lancaster J, Kitchen J, et al. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998; 92:83-92.
30. Vindis C, Cerretti DP, Daniel TO, Huynh-Do U. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis. J Cell Biol 2003; 162:661-671.
31. Elowe S, Holland SJ, Kulkarni S, Pawson T. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol Cell Biol 2001; 21:7429-7441.
32. Miao H, Wei BR, Peehl DM, et al. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 2001; 3:527-530.
33. Kane LP, Andres PG, Howland KC, et al. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol 2001; 2:37-44.
34. Wolfram S. A new kind of science. 1st ed. Champaign, IL: Wolfram Media; 2002.